Anti-C. albicans x Anti-CD64 Bispecific Antibody (IgG-IgG) (BSIG-023)

Anti-C. albicans x Anti-CD64 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-C. albicans and anti-CD64 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can retarget of neutrophils to Candida albicans. It is designed for the research of Candida albicans infection therapy.

Datasheet INQUIRY

Specifications

Targets

C. albicans & CD64

Type

IgG-IgG

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Candida albicans infection

Targets

Target 1

C. albicans

Alternative Names

C. albicans; Candida albicans; Debaryomycetaceae; Candida

Target 2

CD64

Gene ID

2209

UniProt ID

P12314

Alternative Names

FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Related products of "C. albicans & CD64"

See other bsAb targets related to "CD64"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Anti-C. albicans x Anti-CD64 Bispecific Antibody (IgG-IgG) (BSIG-023). Click the button below to contact us or submit your feedback about this product.

Anti-C. albicans x Anti-CD64 Bispecific Antibody (IgG-IgG) (CAT#: BSIG-023)

Specifications

Targets

Customer Reviews and Q&As